RNA
Atrium Therapeutics, Inc.
Nasdaq: RNA · San Diego, CA · Healthcare
$11.49-0.42 (-3.53%)Closed
Market Cap$196.5M
Cash$267.8Mmost recent
Runway26 mo$31.1M Q burn
P/E (TTM)—EPS $-0.97
52-Wk Range$11.49 – $16.54
Avg Volume510.5K3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$11.49-57.3%
Pipeline
Drug candidates sponsored by Atrium Therapeutics · ClinicalTrials.gov
No trials found for this sponsor.
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for RNA. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.